Edited by Sandro Sonnino a-Synuclein (a-syn), which causally links to Parkinson's disease, binds to vesicles containing phosphatidic acid (PA). However, the effects of the fatty acyl chains of PA on its ability to bind to a-syn protein remain unclear. Intriguingly, we reveal that among several PA species, 18:1/18:1-PA is the most strongly bound PA to the a-syn protein. Moreover, 18:1/18:1-PA more strongly enhances secondary structural changes from the random coil form to the a-helical form than 16:0/18:1-PA. Furthermore, 18:1/18:1-PA more markedly accelerates generation of multimeric and proteinase K-resistant a-syn protein compared to 16:0/18:1-PA. These results indicate that among phospholipids examined so far, 18:1/18:1-PA demonstrates the strongest binding to a-syn, as well as the most effective enhancement of its secondary structural changes and aggregation formation.
Phosphatidic acid (PA) is a plasma membrane phospholipid and acts as a second messenger to regulate a wide variety of cellular events [1] [2] [3] . PA consists of various molecular species that have different acyl chains at the sn-1 and sn-2 positions, and consequently, mammalian cells contain at least 50 structurally distinct PA species. However, the different roles of each PA species are poorly understood. The main reason for this is that it is difficult to quantify the amounts of PA molecular species using conventional liquid chromatography (LC)/mass spectrometry (MS) methods because PA species are minor components in lipid bilayers. To overcome this difficulty, we recently established a specific LC/MS method for PA species [4, 5] , and found that 16:0/16:0-PA (X:Y=the number of carbon atoms:the number of double bonds) was specifically increased in Neuro-2a cells during retinoic acid-and serum starvation-induced neuronal differentiation [6] .
In the present study, we have attempted to identify 16:0/16:0-PA-binding proteins from the mouse brain via a screening method using 16:0/16:0-PA-containing liposome precipitation and MS analysis. Intriguingly, we have found that a-synuclein (a-syn) bound to 16:0/16:0-PA. a-Syn is abundantly expressed in the brain and is especially enriched in presynaptic nerve terminals [7, 8] . However, its physiological function remains unclear. On the other hand, a-syn has been implicated in Parkinson's disease [9] because a-syn is the main component of Lewy bodies in patients with the disease as well as in Lewy bodies of patients suffering from Abbreviations CD, circular dichroism; Chol, cholesterol; DG, diacylglycerol; DGK, diacylglycerol kinase; LC, liquid chromatography; LPC, lysophosphatidylcholine; MS, mass spectrometry; PA, phosphatidic acid; PC, phosphatidylcholine; PK, proteinase K; PS, phosphatidylserine; a-syn, a-synuclein.
dementia [10] . Interestingly, a-syn has been reported to bind to vesicles containing acidic phospholipids, such as phosphatidylserine (PS) [11] and PA [12, 13] . The asyn protein has seven repeats of the conserved KTKEGV motif [14] , and its lysine residues are important for interacting with acidic phospholipids [15] . However, these studies generally use only 16:0/18:1-PA because this species exists abundantly in the brain. Thus, the effects of differences in the acyl chain composition of PA species on the interaction with a-syn are poorly understood. Therefore, in the present study, we characterized the binding activities of a-syn using several PA species, including 16:0/16:0-PA, 16:0/18:1-PA, 18:1/18:1-PA, 18:0/18:0-PA and 18:0/20:4-PA. In addition, secondary structural changes and aggregation of a-syn by PA species were also analyzed.
Materials and methods

Materials
L-a-Phosphatidylcholine (PC) from egg yolk and 1-palmitoyl-2-oloyl-sn-glycero-3-phophocholine (16:0/18:1-PC) were purchased from Sigma-Aldrich (St. Louis, MO, USA). 1,2-Dipalmitoyl-sn-glycero-3-phosphate (16:0/16:0-PA), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate (16:0/18:1-PA), 1,2-dioleoyl-sn-glycero-3-phosphate (18:1/18:1-PA), 1,2-distealoyl-sn-3-phosphate (18:0/18:0-PA), 1-stearoyl-2-arachidonoylsn-glycero-3-phosphate (18:0/20:4-PA), 1,2-dipalmitoyl-sn-glycero-3-phosphoserine (16:0/16:0-PS) and 1,2-dioleoyl-sn-glycero-3-phosphoserine (18:1/18:1-PS) were obtained from Avanti Polar Lipids (Alabaster, AL, USA). Cholesterol (Chol) was purchased from Wako Pure Chemical Industries (Osaka, Japan).
Preparation of liposome
The following lipid mixtures were used to identify the 16:0/ 16:0-PA-specific binding protein from the mouse brain: 16:0/16:0-PS liposome (PC (80 mol%) and 16:0/16:0-PS (20 mol%)) and 16:0/16:0-PA liposome (PC (80 mol%) and 16:0/16:0-PA (20 mol%)). The combined dried lipid mixture was resuspended in HEPES buffer (25 mM HEPES, pH 7.4, 100 mM NaCl, 1 mM dithiothreitol). Then, the lipid mixture was vortexed for 1 min. Liposome formation was induced by sonication at 75°C using a Branson Sonifier 450.
The following lipid mixtures were used to determine the properties of the a-syn protein: the control liposome: Chol (50 mol%) and 16:0/18:1-PC (50 mol%); the PA liposome: Chol (50 mol%), 16:0/18:1-PC (35 mol%) and each PA species (15 mol%). For the lipid-binding assay and PKresistance assay, the combined dried lipid mixture was resuspended in HEPES buffer (25 mM HEPES, pH 7.4, 100 mM NaCl, 1 mM dithiothreitol). For the circular dichroism (CD) spectrum, the combined dried lipid mixture was resuspended in a solution consisting of 25 mM HEPES (pH 7.4). Then, the lipid mixture was vortexed for 1 min. Liposome formation was induced by sonication at 75°C using a Branson Sonifier 450.
Identification of a-syn as a PA-binding protein (Fig. S1 ). In-gel digestion and MS identification of proteins in the~19 kDa bands were performed as previously described [16] . Purified peptides were introduced from the high-performance LC to a LTQ-Orbitrap XL (Thermo Scientific, Waltham, MA, USA), a hybrid ion-trap Fourier transform mass spectrometer.
Protein expression and purification His-tagged a-syn protein in the supernatants was purified by Ni-affinity chromatography using a Ni Sepharose 6 fast flow column (GE Healthcare, Little Chalfont, UK) at 4°C (Fig. S2 ). For the lipid-binding and proteinase K (PK)-resistance assay, the purified proteins were dialyzed in HEPES buffer (25 mM HEPES, pH 7.4, 100 mM NaCl, 1 mM dithiothreitol). For the CD spectrum measurement, the purified a-syn protein was dialyzed in a solution consisting of 25 mM HEPES (pH 7.4). The protein concentration was measured with a bicinchoninic acid protein assay kit (Thermo Fisher Scientific).
Lipid-binding assay
The purified a-syn protein (3 lM) was dissolved in HEPES buffer and incubated with the control or PA-containing liposomes at room temperature for 1 h. Then, samples were centrifuged at 200 000 g at 25°C for 1 h using CS100GX II centrifuge and S100AT3 angle rotor (Hitachi Koki, Tokyo, Japan). The precipitant was dissolved in the HEPES buffer.
CD spectrum
The purified a-syn protein (20 lM) was dissolved in a solution consisting of 25 mM HEPES (pH 7.4) and incubated with the control as well as 16:0/18:1-PA or 18:1/18:1-PA liposomes at room temperature for 1 h. Far-ultraviolet CD measurements were performed at room temperature using a JASCO J-805 spectrophotometer (Jasco Analytical Instruments, Tokyo, Japan) with a 0.2-mm quartz cuvette (Starna Scientific, Hainault, UK). Each experiment was reported as the average of five accumulated scans. The protein secondary structure was estimated using the CDSSTR algorithm [17] via the DichroWeb interface [18, 19] .
PK-resistance assay
Purified a-syn was incubated with the control as well as 16:0/18:1-PA or 18:1/18:1-PA liposomes at 37°C for 14 days as previously described [20] . Then, a-syn was digested with PK (0, 0.01, 0.1, 1, 10 lgÁmL À1 ) at 37°C for 20 min. The a-syn protein was detected by western blotting using an anti-a-synuclein antibody (Santa Cruz Biotechnologies, Dallas, TX, USA). The band intensity of the a-syn protein was measured by IMAGE-J software (National Institutes of Health, Bethesda, MD, USA).
Statistical analysis
Statistical analysis was performed by the two-tailed t test or ANOVA followed by Tukey's post hoc test. (Fig. S1 ). a-Syn was identified as a 16:0/16:0-PA-binding protein from the~19 kDa band using the in-gel digestion and MS analysis.
Interaction between a-syn and PA molecular species 16:0/18:1-PA, a major PA species in the mouse brain, is commonly used in a-syn binding assays [12, 13, 21] . Therefore, the effects of differences in the acyl chain composition of PA species on the interaction with asyn are poorly understood. We attempted to characterize the binding activities of a-syn to several PA species, (Fig. 1B,D) . However, the binding activity of 18:1/18:1-PA was considerably higher than that of 18:1/18:1-PS (2.4-fold) (Fig. 1C,D) .
Effect of the 18:1/18:1-PA-containing liposome on the secondary structure of a-syn Because a-syn forms a-helices upon binding to membranes containing acidic phospholipids [21, 22] , the formation of a helical structure in a-syn in the presence of 18:1/18:1-PA was measured using CD spectroscopy. The a-syn protein (20 lM) was incubated with the control as well as 16:0/18:1-PA or 18:1/18:1-PA liposomes, and the CD spectra were measured at 190-260 nm wavelengths ( Fig. 2A) . The a-syn protein had the negative maxima at approximately 200 nm ( Fig. 2A , thin dot line), which are characteristic of a random coil. Although the control liposome did not affect the CD spectrum of the a-syn protein ( Fig. 2A, thin solid Secondary structural analysis using the CDSSTR algorithm [17] showed that 16:0/18:1-and 18:1/18:1-PA augmented the a-helix content of a-syn (38% and 53%, respectively) compared to a-syn alone and the control liposome (4% and 5%, respectively) (Fig. 2B) . On the other hand, the 16:0/18:1-PA and 18:1/18:1-PA liposomes decreased the unordered content of a-syn (39% and 29%, respectively) compared to a-syn alone and the control liposome (71% and 73%, respectively). The b-strand and b-turn forms were not markedly affected under these conditions. These data confirmed that 18:1/18:1-PA more strongly enhanced the secondary structural change in the a-syn protein from random coil to a-helix than 16:0/18:1-PA.
Aggregation formation of a-syn by 18:1/18:1-PAcontaining liposomes
Parkinson's disease is characterized by the presence of Lewy bodies that have characteristic inclusions of aggregated a-syn [9] . In addition, the presence of acidic lipid vesicles has been shown to stimulate a-syn aggregation/fibril formation in vitro [23] . Thus, we examined whether the 18:1/18:1-PA liposomes more strongly enhanced aggregation of the a-syn protein, which was measured by oligomer formation and PKresistance, compared to the control and 16:0/18:1-PA liposomes. Purified a-syn protein was incubated with the control as well as 16:0/18:1-PA or 18:1/18:1-PA liposomes at 37°C for 14 days. Then, the a-syn protein was treated with PK (0-10 lgÁmL À1 ) and detected using an anti-a-syn antibody (Fig. 3A) . To evaluate the oligomer formation of a-syn, monomeric a-syn (~19 kDa) and oligomeric a-syn (~38 and~76 kDa) without PK treatment were measured. As shown in Fig. 3B The amounts of a-syn protein in the supernatant (S) and precipitant (P) were quantified by densitometry using IMAGE-J software (n = 3-4). The binding activity was calculated as the percentage of the precipitate band intensity compared to the total band intensities (supernatant and precipitate). Values are presented as the mean AE S.D. *P < 0.05, **P < 0.01, ***P < 0.005 versus control liposome, #P < 0.05, ### P < 0.005 versus 18:1/18:1-PA liposome.
( Fig. 3A,C) . However, 18:1/18:1-PA liposomes more strongly promoted the formation of PK-resistant a-syn protein at 0.1 lgÁmL À1 PK compared to the control liposomes. In contrast to 18:1/18:1-PA, the formation of PK-resistant a-syn protein was not significantly affected by 16:0/18:1-PA. These data suggest that 18:1/ 18:1-PA more strongly promotes the abnormal aggregation of a-syn protein compared to 16:0/18:1-PA.
Discussion
It has been reported that the a-syn protein binds to acidic phospholipids, including PA and PS, and that PS binds to the a-syn protein with almost the same intensity as PA [12] . However, the a-syn/acidic phospholipid-binding assay has commonly only employed 16:0/18:1-PA [12, 13, 21] because this species is the major species in the brain [24] . Therefore, the effects of the differences in the acyl chain composition of PA on the interaction with a-syn are poorly understood.
The present study provides important information about the effects of the fatty acyl composition of PA for the a-syn-binding ability. We clearly demonstrated that 18:1/18:1-PA showed stronger binding to the asyn protein than PS and 16:0/18:1-PA, which is generally used in most studies. Therefore, it is likely that ) at 37°C for 20 min. The a-syn protein was detected by western blotting using an anti-a-syn antibody. The representative data from three independent experiments are shown. (B, C). The amount of monomeric and oligomeric a-syn protein was quantified by densitometry using IMAGE-J software (n = 3). Values are presented as the mean AE SD. *P < 0.05, **P < 0.01, ***P < 0.005.
18:1/18:1-PA is the strongest binding partner of a-syn among the phospholipids examined so far.
Although a-syn was identified by a screening method using the 16:0/16:0-PA liposome, this PA species did not intensely bind to a-syn (Fig. 1B) . On the other hand, the a-syn protein strongly bound to 16:0/ 18:1-, 18:1/18:1-and 18:0/20:4-PA (Fig. 1B) . These PA species commonly contain monounsaturated or polyunsaturated fatty acyl chains. Notably, 18:1/18:1-PA demonstrated the strongest binding to the a-syn protein among them (2.9-and 3.1-fold stronger than 16:0/18:1-and 18:0/20:4-PA, respectively) (Fig. 1B) . Although 18:1/18:1-PA has two unsaturated fatty acyl chains, 16:0/18:1-and 18:0/20:4-PA only have one unsaturated fatty acyl chain, suggesting that two unsaturated fatty acyl chains in PA species are important for a-syn binding. It is possible that the two unsaturated fatty acyl chains contained in 18:1/18:1-PA contribute to the increase in membrane fluidity to a level that is suitable for a-syn binding.
Several PA targets were reported to display negative curvature-dependence in their binding to PA [25] . Lysophosphatidylcholine (LPC) and diacylglycerol (DG) induce positive and negative curvature stress, respectively [25] . Thus, we repeated the binding experiment with 18:1/18:1-PA and adding 1 mol% 18:1/18:1-DG or 1 mol% 18:1-LPC. However, 18:1/18:1-DG and 18:1-LPC failed to change binding activities between 18:1/18:1-PA liposomes and a-syn (data not shown), suggesting that curvature stress does not contribute strongly to generating the different a-syn-binding intensities of distinct PA species.
18:1/18:1-PA more intensely increased the a-helical content of the a-syn protein compared to 16:0/18:1-PA (Fig. 2B) as well as more strongly enhanced the oligomer formation (Fig. 3B ) and PK-resistance (Fig. 3C) of the a-syn protein than 16:0/18:1-PA. These results seem to reflect the interaction intensities between the a-syn protein and these PA species (Fig. 1B) . Therefore, these results strongly suggest that in addition to binding activity, 18:1/18:1-PA has the strongest binding to asyn and leads to the greatest enhancement of a-helix conversion and aggregation formation of the protein among the acidic phospholipids analyzed so far.
Aging remains the biggest risk factor for developing sporadic Parkinson's disease [26] . Interestingly, PA increased in aged male mice (12-14 months old), but PS decreased with age [24] . This finding correlates with the statistical analysis, indicating that Parkinson's disease incidence is 1.5 times greater in men than women [27, 28] . In our data, 18:1/18:1-PA strongly enhanced oligomer formation (Fig. 3B ) and PK-resistance (Fig. 3C) [24] ), over the course of aging primarily enhances the abnormal aggregation of the a-syn protein.
In mammalian cells, PA is generated by de novo synthesis [29] , phosphorylation of DG by DG kinase (DGK) [30] [31] [32] [33] and hydrolysis of PC by phospholipase D [34] [35] [36] . Interestingly, single nucleotide polymorphisms (rs1564282, rs11248060) of DGKQ (DGKh gene), one of 10 DGK isozyme genes in mammals, have been reported to be associated with the risk of Parkinson's disease [37] in Caucasian [38, 39] and Chinese [40] populations. Moreover, DGKh is highly expressed in the cerebellum and hippocampus in the adult rat brain [41] . Furthermore, overexpression of DGKh mainly increased the amount of 18:1/18:1-PA in mouse primary hepatocytes [42] . Therefore, these results imply that the abnormal aggregation of the a-syn protein results from 18:1/18:1-PA production by DGKh in the brain.
In conclusion, 18:1/18:1-PA demonstrated a substantially stronger enhancement of generation of a-helical, multimeric and PK-resistant a-syn protein than 16:0/ 18:1-PA and PS, which have been reported to be representative a-syn-binding acidic phospholipids. Therefore, it is likely that the contribution of PA to the aggregation formation of a-syn is greater than expected so far. Information on a-syn binding to distinct PA molecular species revealed by this study indicates the importance of the lipid composition (especially PA molecular species contents) in the a-syn-membrane interaction. The very dynamic structural change in a-syn in response to a specific PA molecular species, 18:1/18:1-PA, which increased with aging, will likely be important for understanding its propensity to aggregate and accumulate in Parkinson's disease. Areas), 25116704 (Grant-in-Aid for Scientific Research on Innovative Areas), 26291017 (Grant-in-Aid for Scientific Research (B)), and 15K14470 (Grant-in-Aid for Challenging Exploratory Research); the Japan Science and Technology Agency (AS221Z00794F, AS231Z00139G, AS251Z01788Q, and AS2621643Q); the Naito Foundation; the Hamaguchi Foundation for the Advancement of Biochemistry; the Daiichi-Sankyo
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